Treatment of bilateral Irvine-Gass syndrome with suprachoroidal triamcinolone injection.

Authors

Fatima Zahra, Sara Rashid, Marium Anis, Khadijah Abid, Haroon Tayyab

Published in

BMJ case reports. Volume 19. Issue 9. Sep 21, 2026. Epub Sep 21, 2026.

Abstract

A woman in her 60s underwent uneventful sequential cataract surgeries for both eyes and achieved 6/6 visual acuity postoperatively. 7 weeks after surgery, she developed bilateral cystoid macular oedema (CME) and her vision declined to a best-corrected visual acuity (BCVA) of 6/21 in the right eye and 6/24 in the left eye. She was diagnosed with bilateral Irvine-Gass syndrome (IGS). Initial treatment with topical steroids and non-steroidal anti-inflammatory drugs was ineffective. She was subsequently treated with a single dose of suprachoroidal triamcinolone acetonide (SCTA) injections (40 mg/mL) in each eye. This intervention led to a rapid and complete resolution of CME within 2 weeks. Her BCVA recovered to 6/6 in both eyes and remained stable for 8 months post-SCTA injections.This case highlights that SCTA may represent a promising treatment option for IGS, offering successful anatomical and functional outcomes in patients who do not respond to conventional topical therapy.

PMID:
42767792
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.